Home | Welcome to Contract Pharma   
Last Updated Monday, December 22 2014

Print

Biosimilar



A product approved or on track for approval through abbreviated approval pathways in the U.S., Europe and other countries, based largely on similarities and comparisons with an already-approved reference biologic product.


blog comments powered by Disqus

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On